Varlilumab Biosimilar - Research Grade

Varlilumab Biosimilar - Research Grade, Human IgG4
Artikelnummer
ICH5022-10MG
Verpackungseinheit
10mg
Hersteller
Ichorbio

Verfügbarkeit: wird geladen...
Preis wird geladen...
Target: CD27.

Specificity: Detects human CD27. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Varlilumab.

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: Varlilumab is a monoclonal antibody designed for immunotherapy for solid tumors and hematologic malignancies. It is an anti-CD27 antibody and helps activate T-cells.

Concentration: 5mg/ml.

Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity: >95% by SDS-PAGE.

Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method.

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Mehr Informationen
Artikelnummer ICH5022-10MG
Hersteller Ichorbio
Hersteller Artikelnummer ICH5022-10MG
Green Labware Nein
Verpackungseinheit 10mg
Mengeneinheit STK
Reaktivität Human
Klonalität Monoclonal
Methode Functional Assay
Isotyp Human IgG4
Produktinformation (PDF) Download
MSDS (PDF) Download